$0.83
+0.00 (+0.31%)
Open$0.83
Previous Close$0.83
Day High$0.85
Day Low$0.80
52W High$12.23
52W Low$0.74
Volume—
Avg Volume15.14M
Market Cap13.16M
P/E Ratio—
EPS$-4.49
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+5,157.3% upside
Current
$0.83
$0.83
Target
$43.72
$43.72
$35.70
$43.72 avg
$58.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.64M | 4.18M | 3.97M |
| Net Income | -96,676,853 | -1,151,363 | -1,086,006 |
| Profit Margin | -16,993.3% | -27.6% | -27.4% |
| EBITDA | -96,849,474 | -1,394,086 | -1,159,340 |
| Free Cash Flow | — | -921,744 | -1,324,564 |
| Rev Growth | — | +11.5% | +10.2% |
| Debt/Equity | — | 0.72 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |